{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-012740","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2025-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.403204+00:00","generated_at":"2026-05-27T09:05:49.131328+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vanda files NDA for tradipitant to treat motion sickness","bullets":["Vanda disclosed via 8-K that it filed a New Drug Application for tradipitant for motion sickness.","Announcement made via social media post on X on January 25, 2025, referencing WWII context.","No approval or timeline provided; filing is a regulatory step toward potential commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-012740","json":"https://secwatch.observer/filing/0001193125-25-012740.json","markdown":"https://secwatch.observer/filing/0001193125-25-012740.md","text":"https://secwatch.observer/filing/0001193125-25-012740.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000119312525012740/0001193125-25-012740-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000119312525012740/d869105d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T09:05:49.131328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}